Tim-3 on natural killer cells regulates immune response via antibody dependent cellular cytotoxicity in HER2-positive gastric cancer

ABSTRACT: The present study suggests that combined therapy with anti-Tim-3 antibodies and trastuzumab can be a new treatment strategy for HER2-positive GC.

ORGANISM(S): Homo sapiens

PROVIDER: GSE254188 | GEO | 2024/12/26

REPOSITORIES: GEO